| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $134.0M | +39.4% |
| Cost of Revenue | $8.8M | +199.1% |
| R&D Expense | $187.8M | -26.9% |
| SG&A Expense | $120.2M | -11.8% |
| Operating Income | -$182.7M | +39.1% |
| Pre-tax Income | -$178.2M | +40.6% |
| Income Tax | $0 | — |
| Net Income | -$178.9M | +40.3% |
| EPS (Basic) | -$2.37 | +54.1% |
| EPS (Diluted) | -$2.37 | +54.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64.7M | -25.6% |
| Accounts Receivable | $22.4M | +8.9% |
| Inventory | $20.6M | +45.6% |
| Current Assets | $393.0M | +15.9% |
| Total Assets | $454.0M | +5.7% |
| Current Liabilities | $86.5M | -10.6% |
| Total Liabilities | $112.3M | -10.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$152.9M | +36.5% |
| Capital Expenditures | $841K | -57.3% |
| Investing Cash Flow | -$34.3M | -119.4% |
| Financing Cash Flow | $165.0M | +1008.1% |
| Free Cash Flow | -$153.7M | +36.7% |
| Stockholders' Equity |
| $341.7M |
| +12.1% |